Internal Medicine, Interventional Cardiology · Van Nuys, CA
NPI
1619964095
Since 2005
Specialty
Internal Medicine, Interventional Cardiology
Code 207RI0011X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
14411 Hamlin St
Van Nuys, CA, 91401
Phone (818) 994-0616
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.2M
9,307 services
Medicare patients, 2024
578
Average age 73
Drug cost, 2024
$388K
7,376 prescriptions
Company payments, 2025
$80.3
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ramesh K Arora was code 99213 (office e&m - established), 2,054 times for 535 patients. In total Ramesh K Arora billed 9,307 services in 33 codes, and Medicare paid $1.2M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-11-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 2,054 | 535 | $82.60 | $170K |
| 99211 Office E&M - Established | Office | 1,291 | 476 | $22.23 | $29K |
| 99484 Behavioral Health Services | Office | 1,169 | 479 | $49.73 | $58K |
| J2785 Injection, regadenoson, 0.1 mg | Office | 869 | 218 | $5.43 | $4,717 |
| 93000 Electrocardiogram | Office | 851 | 442 | $13.26 | $11K |
| 93306 Echocardiography (TTE/TEE) | Office | 428 | 420 | $188.95 | $81K |
| A9555 Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 372 | 187 | $441.55 | $164K |
| 93880 Duplex Scan - Extracranial Arteries | Office | 282 | 282 | $184.75 | $52K |
| 99214 Office E&M - Established | Office | 244 | 176 | $114.38 | $28K |
| 93015 Electrocardiogram | Office | 221 | 221 | $67.38 | $15K |
| 96374 Injection Administration | Office | 209 | 208 | $35.95 | $7,514 |
| 78434 Myocardial Perfusion Scan | Office | 186 | 186 | $130.83 | $24K |
| 78431 Myocardial Perfusion Scan | Office | 186 | 186 | $1,841.65 | $343K |
| 36415 Venipuncture Blood Collection | Office | 176 | 118 | $8.65 | $1,522 |
| 93970 Duplex Scan - Extremity Veins | Office | 115 | 114 | $184.62 | $21K |
By year: 2022 $759K for 9,344 services; 2023 $886K for 7,256 services; 2024 $1.2M for 9,307 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 176 | 118 | $8.65 | $1,522 |
Medicare prescription drug claims, 2024
In 2024, the drug Ramesh K Arora prescribed most often to Medicare patients was Nitroglycerin, with 725 prescriptions and refills. In total Ramesh K Arora wrote 7,376 Medicare prescriptions that cost $388K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Nitroglycerin Generic | 725 | 861 | 255 | $12K |
| Metoprolol Succinate Generic | 716 | 1,081 | 182 | $5,679 |
| Isosorbide Mononitrate Er Isosorbide Mononitrate | 527 | 827 | 149 | $3,965 |
| Atorvastatin Calcium Generic | 453 | 782 | 152 | $2,110 |
| Amlodipine Besylate Generic | 417 | 703 | 141 | $959 |
| Rosuvastatin Calcium Generic | 316 | 423 | 70 | $2,268 |
| Carvedilol Generic | 313 | 514 | 84 | $1,082 |
| Hydralazine Hcl Generic | 268 | 409 | 77 | $2,167 |
| Clonidine Hcl Generic | 265 | 325 | 78 | $819 |
| Losartan Potassium Generic | 225 | 363 | 74 | $1,068 |
| Metoprolol Tartrate Generic | 194 | 293 | 48 | $688 |
| Cilostazol Generic | 184 | 252 | 46 | $2,200 |
| Eliquis Apixaban | 176 | 297 | 50 | $171K |
| Ranolazine Er Ranolazine | 171 | 222 | 38 | $13K |
| Propranolol Hcl Generic | 171 | 279 | 49 | $2,382 |
Brand drugs: 525 claims; generic drugs: 6,851 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ramesh K Arora $80.3 ($80.3 in general payments such as food, travel and fees) from 3 companies. The largest payer was Abbott Laboratories with $34.06.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.